Page 48 - Anjali Singh

Glenmark cuts diabetes drug cost by 70% with first Indian biosimilar launch

Drug, marketed under the brand name Lirafit, is priced at approximately Rs 100 for a standard daily dose of 1.2 mg

Dr Reddy's Laboratories acquires women's health brands from MenoLabs

DRL said that it has acquired the entire MenoLabs supplements portfolio, which includes seven branded products designed to provide health support and address symptoms of perimenopause and menopause

BDR Pharmaceuticals launches prostate cancer drug in oral solution form

BDR stated since BDENZA is in liquid form, they can't quantify how lower it is compared to its counterparts in the market as they are present in solid form (tablet/capsule)

Alembic Pharmaceuticals clinches eight USFDA approvals in Q3 FY24

The same day, Alembic Pharma's share price rose to 3.55 per cent, ending the day's trade at Rs 792 apiece on the BSE

Festive cheer drives up TVS, Bajaj sales: Two-wheeler boom, export boost

Bajaj Auto reported that the domestic two-wheeler segment witnessed a 26 per cent growth, with sales climbing to 158,370 units in December 2023 from 125,553 units in December 2022

JK Tyre successfully raises Rs. 500 cr through QIP for growth initiatives

The funds raised will be utilised for both strengthening the balance sheet and growing capex

Nephrocare India raises Rs 8.08 crore in pre IPO round, eyes 300 clinics

Founded in 2014, Nephrocare India operates three kidney care clinics in West Bengal and a flagship holistic healthcare facility in Salt Lake, Kolkata

IIL invests Rs 700 cr in new vaccine plant to combat livestock disease

Equipped with a BSL3 (biosafety level) facility for drug substance production and a Fill-Finish capability for final vaccine products, the unit will focus on combating two major livestock diseases

Corporates relook at work-from-home policy as Covid cases resurge

India reports a single-day spike of 702 cases; 6 deaths

Smaller electric two-wheeler players unlikely to raise prices in 2024

The prices of E2Ws range from Rs 90,000 to Rs 1 lakh, the players being Lohia Auto, Godawari Electric, Emobi, etc

Tata Motors bags order to provide 1,350 diesel bus chassis to UPSRTC

Tata Motors has supplied over 58,000 buses to various state and public transport undertakings to date

Aurobindo Pharma's new injectable facility get 10 observations from US FDA

"The observations are procedural and will be responded to within the stipulated time," the company stated in a regulatory filing

Lupin expands global portfolio with acquisition of assets from Sanofi

The deal involves the acquisition of a portfolio of accretive established products in Europe and Canada

Two wheeler year-end discounts flat, riding on inventory liquidation

The recent festive season saw robust growth in two-wheeler sales, reaching 2,893,107 units, marking a 20.71 per cent increase compared to the previous year

Emcure Pharmaceuticals refiles IPO papers to Sebi, trims issue size

The company had first submitted draft papers for its IPO in August 2021

Aurobindo Pharma gets 'Voluntary Action Indicated' classing from US FDA

The classification follows an inspection conducted by the FDA from September 13 to September 19, 2023

Only 18% tested, India risks undetected community spread of JN.1: Study

JN.1 cases have been detected in the US, China, and India. Official figures from India show just over 1700 active cases nationwide

Biocon Biologics completes integration of Viatris' biosimilars business

Biocon Biologics bought Viatris' global biosimilars business last year to become one of the top five global players in the space

Indian companies likely to garner up to 50% USFDA nod share in 2023

Companies may get up to 375 ANDA approvals in 2023, more than last year's 355

Cipla invests Rs 42 crore in GoApptiv to enhance healthcare access

Cipla's move aligns with its vision to strengthen investments in channels and technologies